title: A case of aseptic meningitis without neck rigidity occurring in a metastatic melanoma patient treated with ipilimumab.
authors.affiliation: Department of Dermatology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
authors.forename: Kyosuke
authors.initials: K
authors.lastname: Oishi
authors.affiliation: Department of Dermatology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
authors.forename: Masaharu
authors.initials: M
authors.lastname: Nakao
authors.affiliation: Department of Dermatology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
authors.forename: Shintaro
authors.initials: S
authors.lastname: Maeda
authors.affiliation: Department of Dermatology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
authors.forename: Takashi
authors.initials: T
authors.lastname: Matsushita
authors.affiliation: Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate of Medical Science, Kanazawa, Japan.
authors.forename: Tokuhei
authors.initials: T
authors.lastname: Ikeda
authors.affiliation: Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
authors.forename: Tadaaki
authors.initials: T
authors.lastname: Yamada
authors.affiliation: Department of Dermatology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
authors.forename: Kazuhiko
authors.initials: K
authors.lastname: Takehara
authors.affiliation: Department of Dermatology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
authors.forename: Yasuhito
authors.initials: Y
authors.lastname: Hamaguchi
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects; D000074322:Antineoplastic Agents, Immunological / Q000009:adverse effects*; D006258:Head and Neck Neoplasms / Q000188:drug therapy; D006801:Humans; D000074324:Ipilimumab / Q000009:adverse effects*; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D008582:Meningitis, Aseptic / Q000139:chemically induced* / Q000188:drug therapy; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy
chemical_list: D000911:Antibodies, Monoclonal; D000074322:Antineoplastic Agents, Immunological; D000074324:Ipilimumab; D018696:Neuroprotective Agents; D008775:Methylprednisolone